IN2013MU03015A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03015A
IN2013MU03015A IN3015MU2013A IN2013MU03015A IN 2013MU03015 A IN2013MU03015 A IN 2013MU03015A IN 3015MU2013 A IN3015MU2013 A IN 3015MU2013A IN 2013MU03015 A IN2013MU03015 A IN 2013MU03015A
Authority
IN
India
Prior art keywords
inhibition
compounds
formula
cell growth
unregulated cell
Prior art date
Application number
Other languages
English (en)
Inventor
Pangavhane Kailas
Athavale Maithili
Original Assignee
Godavari Biorefineries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Godavari Biorefineries Ltd filed Critical Godavari Biorefineries Ltd
Priority to PCT/IN2014/000622 priority Critical patent/WO2015044960A2/en
Priority to IN3015MU2013 priority patent/IN2013MU03015A/en
Priority to CA2925218A priority patent/CA2925218A1/en
Priority to EP14849098.0A priority patent/EP3049083A4/en
Priority to US15/024,980 priority patent/US20160214941A1/en
Priority to BR112016006664A priority patent/BR112016006664A2/pt
Priority to JP2016517547A priority patent/JP2017506617A/ja
Publication of IN2013MU03015A publication Critical patent/IN2013MU03015A/en
Priority to IL244730A priority patent/IL244730A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IN3015MU2013 2013-09-26 2014-09-26 IN2013MU03015A (en])

Priority Applications (8)

Application Number Priority Date Filing Date Title
PCT/IN2014/000622 WO2015044960A2 (en) 2013-09-26 2014-09-26 Compounds for inhibition of unregulated cell growth
IN3015MU2013 IN2013MU03015A (en]) 2013-09-26 2014-09-26
CA2925218A CA2925218A1 (en) 2013-09-26 2014-09-26 Compounds for inhibition of unregulated cell growth
EP14849098.0A EP3049083A4 (en) 2013-09-26 2014-09-26 Compounds for inhibition of unregulated cell growth
US15/024,980 US20160214941A1 (en) 2013-09-26 2014-09-26 Compounds for lnhibition of Unregulated Cell Growth
BR112016006664A BR112016006664A2 (pt) 2013-09-26 2014-09-26 compostos para a inibição do crescimento celular desregulado
JP2016517547A JP2017506617A (ja) 2013-09-26 2014-09-26 未制御細胞成長の阻害のための化合物
IL244730A IL244730A0 (en) 2013-09-26 2016-03-23 Compounds to prevent uncontrolled cell growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3015MU2013 IN2013MU03015A (en]) 2013-09-26 2014-09-26

Publications (1)

Publication Number Publication Date
IN2013MU03015A true IN2013MU03015A (en]) 2015-07-17

Family

ID=52744636

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3015MU2013 IN2013MU03015A (en]) 2013-09-26 2014-09-26

Country Status (8)

Country Link
US (1) US20160214941A1 (en])
EP (1) EP3049083A4 (en])
JP (1) JP2017506617A (en])
BR (1) BR112016006664A2 (en])
CA (1) CA2925218A1 (en])
IL (1) IL244730A0 (en])
IN (1) IN2013MU03015A (en])
WO (1) WO2015044960A2 (en])

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3626703A4 (en) * 2017-05-16 2020-12-16 Industry-Academic Cooperation Foundation, Yonsei University NEW COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THIS AS AN ACTIVE SUBSTANCE
CN113061118B (zh) * 2021-04-08 2022-05-27 株洲九派科技发展有限公司 一种吩嗪-查尔酮杂合化合物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767919B2 (en) * 2002-12-17 2004-07-27 Walker Cancer Research Institute, Inc. High specificity anticancer agents
US6821983B2 (en) * 2003-04-04 2004-11-23 Academia Sinica 5-(9-acridinylamino)-toluidine compounds
WO2008135886A2 (en) * 2007-05-02 2008-11-13 University Of Pretoria Quinoline derivatives for use in the inhibition of the growth of tumour cells

Also Published As

Publication number Publication date
BR112016006664A2 (pt) 2017-08-01
EP3049083A2 (en) 2016-08-03
IL244730A0 (en) 2016-04-21
WO2015044960A2 (en) 2015-04-02
EP3049083A4 (en) 2017-11-22
CA2925218A1 (en) 2015-04-02
JP2017506617A (ja) 2017-03-09
WO2015044960A3 (en) 2017-01-19
US20160214941A1 (en) 2016-07-28

Similar Documents

Publication Publication Date Title
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
MY184733A (en) Pyrimidine fgfr4 inhibitors
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
PH12016500225B1 (en) Novel quinoline-substituted compound
JO3317B1 (ar) مركبات تترا هيدروبيرولو ثيازين
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
PH12016500169A1 (en) Polymorph of syk inhibitors
UA110338C2 (xx) Хімічні сполуки
PH12015502546A1 (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
IN2015DN00598A (en])
IN2014DN07224A (en])
CR20140495A (es) 5-amino[1,4]thiazines como inhibidores de bace1
MX2015015841A (es) Compuestos de fenoxietil dihidro-1h-isoquinolina.
PH12015502032A1 (en) Azetidinyloxyphenylpyrrolidine compounds
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
MX2015016332A (es) Inhibidores de alk biciclicos fusionados.
IN2014DN07220A (en])
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
IN2014DN07954A (en])
IN2013DE02503A (en])
IN2013MU03015A (en])
MX2016006807A (es) Derivados de imidazol.
DK201300179U1 (da) Kemisk forbindelse med nyttige egenskaber
TN2017000065A1 (en) A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor